Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Peptide blocking enhancer of NMDAR function suppresses pain hypersensitivity

Jan. 9, 2009

Etifoxine aids peripheral nerve recovery

Jan. 9, 2009

GSK scientists describe new AMPA receptor agonists in recent patent

Jan. 8, 2009

Chalcone derivative blocks Abeta impairment of PKA/CREB signaling

Jan. 8, 2009

GlaxoSmithKline reports on discovery of EP1 receptor antagonist for inflammatory pain

Jan. 8, 2009

FDA approves once-daily Ryzolt for moderate to moderately severe pain

Jan. 7, 2009

King provides update on Embeda NDA review

Jan. 7, 2009

Acura and King Pharmaceuticals submit NDA to FDA for Acurox anti-abuse opioid analgesic

Jan. 7, 2009

IGF-1 does not affect outcome measures in phase III amyotrophic lateral sclerosis trial

Jan. 7, 2009

New mgluR2 ligands/5-HT2A antagonists described in Abbott patent

Jan. 5, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...